Results for tag: "Amatuximab"

Amatuximab is a monoclonal antibody used in the treatment of oncology drugs. It is used to treat a variety of cancers, including ovarian, colorectal, and non-small cell lung cancer. It works by targeting a protein called mesothelin, which is found on the surface of cancer cells. This protein helps cancer cells to grow and spread. By targeting this protein, Amatuximab can help to slow down the growth and spread of cancer cells. Amatuximab is administered intravenously and is usually given in combination with other chemotherapy drugs. It is generally well tolerated, with the most common side effects being fatigue, nausea, and diarrhea. The Amatuximab market is a rapidly growing one, with many companies developing and marketing the drug. Some of the major players in the market include Merck, Pfizer, AstraZeneca, and Bristol-Myers Squibb. Show Less Read more